ReviewFrontiers in oncology2022
HPV vaccination in Latin America: Coverage status, implementation challenges and strategies to overcome it.
Review in Frontiers in oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Factors Related To Improving the Quality of Cervical Cancer Screening for Women Living with HIV in La Romana, Dominican Republic: A Qualitative Descriptive Study.AIDS and behavior · 2026Article
- Global and Regional Diagnostic Results of Progress Toward Cervical Cancer Elimination, According to the WHO Strategy: A Systematic Literature Review with Narrative SynthesisDiagnostics (Basel, Switzerland) · 2026Review
- Determinants of HPV vaccine hesitancy in South Asia: a systematic review.Clinical and experimental vaccine research · 2026Review
- Investigation of Youth Attitudes and Opinions Regarding HPV: A Systematic Review.Healthcare (Basel, Switzerland) · 2026Review
- Perceptions of Vaccination in Latin America: Insights from Panama, the Dominican Republic, and Guatemala.Cureus · 2026Article
- Effectiveness and feasibility of vaccination interventions for Indigenous and hard-to-reach populations in Latin America and the Caribbean: a systematic review and meta-analysis.Therapeutic advances in vaccines and immunotherapy · 2026Review
- HPV vaccine awareness and uptake in rural Indigenous communities in Guatemala: a cross-sectional study.BMJ open · 2025Article
- Education and social determinants shaping HPV vaccine uptake: Insights from a nationwide cross-sectional study.Human vaccines & immunotherapeutics · 2025Article
- HPV Vaccine Uptake and Cervical Cancer Trends in Panama: A Reference Point for Future Impact Studies.Vaccines · 2025Article
- Advancements and Future Perspectives of Human Papillomavirus (HPV) Vaccination in Latin America: Insights from Recent Decades.Healthcare (Basel, Switzerland) · 2025Review
- Molecular Insights into HPV-Driven Head and Neck Cancers: From Viral Oncoproteins to Precision Therapeutics.Viruses · 2025Review
- Barriers in the prevention and early detection of human papillomavirus in Latin America.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025Article
- Global disparities in gynecologic cancer outcomes: A call for action.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2025Article
- Papillomavirus Vaccination Programs and Knowledge Gaps as Barriers to Implementation: A Systematic Review.Vaccines · 2025Review
- Human Papilloma Virus Vaccination as a Strategy to Eliminate Cervical Cancer: Challenges and Opportunities.Vaccines · 2025Article
- School-based HPV vaccination program implementation in municipalities of the São Paulo State, Brazil, from 2015 to 2018.Cadernos de saude publica · 2025Article
- No negative effect of mentioning COVID-19 vaccine in influenza vaccine encouragements: Evidence from a survey experiment.PLOS global public health · 2025Article
- Article
- Article
- A Systematic Review of Human Papillomavirus Vaccination Challenges and Strategies to Enhance Uptake.Vaccines · 2024Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer remains a leading cause of morbidity and mortality amongst females in Latin America (LATAM). Cervical cancer is a preventable disease and HPV vaccination is a main key strategy towards its elimination. This study analyzes HPV vaccine implementation current status and the main barriers to achieve adequate coverage in the region. Data from the nineteen sovereign states of LATAM (comprised of all Portuguese and Spanish-speaking nations located south of the United States) were collected, including year of HPV vaccine implementation, gender and age targets, the number of doses included in the public program and coverage by dose. Sixteen out of the 19 evaluated countries have already implemented HPV vaccination programs. However, despite its proven efficacy and safety, HPV vaccine uptake in LATAM has been lower than expected. There is an evident decline in adhesion, mainly regarding the second dose. Several reasons are probably involved, of note: limited knowledge of HPV and HPV vaccine, misguided safety concerns, high cost, cultural barriers, and the Covid19 pandemic. Proper strategies to overcome these barriers are needed to ensure successful uptake. Effective policies are: adopting the one dose schedule, delivering the vaccine on both health center and schools, and advising health professionals to recommend the vaccine. Further research regarding HPV vaccine hesitancy in Latin America is needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.